Lipocine (LPCN) Other Non Operating Income (2018 - 2024)
Lipocine (LPCN) posted Other Non Operating Income of $3,586 for Q4 2024, down 70.8% from $12,274 a year earlier and down 97.4% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Other Non Operating Income (2018 - 2024) Analysis & Trends
For FY2024, Lipocine's Other Non Operating Income came in at $17,166, down 91.9% from FY2023.
- Annual Other Non Operating Income shows a five-year compound annual growth rate of -40.8% (FY2019 to FY2024).
- In prior years, Lipocine's Other Non Operating Income was $212,690 in FY2023 (-62.4%), $565,940 in FY2022, -$3.78 million in FY2021 and -$2.97 million in FY2020.
- Quarterly Other Non Operating Income has run from a low of -$3.82 million in Q2 2021 to a high of $583,445 in Q2 2022 over five years.
- On a year-over-year basis, Other Non Operating Income increased in 1 of the last five quarters, with an average decline of 44.6%.
- The strongest year-over-year quarter for Other Non Operating Income in the past five years was Q3 2021, with growth of 241.7%; the weakest was Q2 2023, with a decline of 95.3%.
- According to Business Quant data, Other Non Operating Income for the three prior quarters was $138,081 (Q3 2024), -$84,430 (Q2 2024) and -$40,072 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Lipocine | 11.22 Mn | -56.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 3,586.00 |
| Sep 30, 2024 | 138,081.00 |
| Jun 30, 2024 | -84,430.00 |
| Mar 31, 2024 | -40,072.00 |
| Dec 31, 2023 | 12,274.00 |
| Sep 30, 2023 | 74,827.00 |
| Jun 30, 2023 | 27,455.00 |
| Mar 31, 2023 | 98,134.00 |
| Dec 31, 2022 | 34,243.00 |
| Sep 30, 2022 | 326,240.00 |
| Jun 30, 2022 | 583,445.00 |
| Mar 31, 2022 | -377,988.00 |
| Dec 31, 2021 | -159,926.00 |
| Sep 30, 2021 | 479,951.00 |
| Jun 30, 2021 | -3.82 Mn |
| Mar 31, 2021 | -253,389.00 |
| Dec 31, 2020 | 290,398.00 |
| Sep 30, 2020 | 140,477.00 |
| Jun 30, 2020 | -2.15 Mn |
| Mar 31, 2020 | -1.17 Mn |
API Access
Lipocine Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();